Browse
Submit Data
Databases
API
Help

Dataset Information

18 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Personalized Dose Finding Using Outcome Weighted Learning.

ABSTRACT: In dose-finding clinical trials, it is becoming increasingly important to account for individual level heterogeneity while searching for optimal doses to ensure an optimal individualized dose rule (IDR) maximizes the expected beneficial clinical outcome for each individual. In this paper, we advocate a randomized trial design where candidate dose levels assigned to study subjects are randomly chosen from a continuous distribution within a safe range. To estimate the optimal IDR using such data, we propose an outcome weighted learning method based on a nonconvex loss function, which can be solved efficiently using a difference of convex functions algorithm. The consistency and convergence rate for the estimated IDR are derived, and its small-sample performance is evaluated via simulation studies. We demonstrate that the proposed method outperforms competing approaches. Finally, we illustrate this method using data from a cohort study for Warfarin (an anti-thrombotic drug) dosing.

SUBMITTER: Chen G

PROVIDER: S-EPMC5327863 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

Personalized Dose Finding Using Outcome Weighted Learning.

Chen Guanhua G Zeng Donglin D Kosorok Michael R MR

Journal of the American Statistical Association 20160101 516

In dose-finding clinical trials, it is becoming increasingly important to account for individual level heterogeneity while searching for optimal doses to ensure an optimal individualized dose rule (IDR) maximizes the expected beneficial clinical outcome for each individual. In this paper, we advocate a randomized trial design where candidate dose levels assigned to study subjects are randomly chosen from a continuous distribution within a safe range. To estimate the optimal IDR using such data, ...[more]

PMID: 28255189

Similar Datasets

Outcome-Weighted Learning for Personalized Medicine with Multiple Treatment Options.

Project description:To achieve personalized medicine, an individualized treatment strategy assigning treatment based on an individual's characteristics that leads to the largest benefit can be considered. Recently, a machine learning approach, O-learning, has been proposed to estimate an optimal individualized treatment rule (ITR), but it is developed to make binary decisions and thus limited to compare two treatments. When many treatment options are available, existing methods need to be adapted by transforming a multiple treatment selection problem into multiple binary treatment selections, for example, via one-vs-one or one-vs-all comparisons. However, combining multiple binary treatment selection rules into a single decision rule requires careful consideration, because it is known in the multicategory learning literature that some approaches may lead to ambiguous decision rules. In this work, we propose a novel and efficient method to generalize outcome-weighted learning for binary treatment to multi-treatment settings. We solve a multiple treatment selection problem via sequential weighted support vector machines. We prove that the resulting ITR is Fisher consistent and obtain the convergence rate of the estimated value function to the true optimal value, i.e., the estimated treatment rule leads to the maximal benefit when the data size goes to infinity. We conduct simulations to demonstrate that the proposed method has superior performance in terms of lower mis-allocation rates and improved expected values. An application to a three-arm randomized trial of major depressive disorder shows that an ITR tailored to individual patient's expectancy of treatment efficacy, their baseline depression severity and other characteristics reduces depressive symptoms more than non-personalized treatment strategies (e.g., treating all patients with combined pharmacotherapy and psychotherapy).

| S-EPMC6437674 | biostudies-literature

Greedy outcome weighted tree learning of optimal personalized treatment rules.

Project description:We propose a subgroup identification approach for inferring optimal and interpretable personalized treatment rules with high-dimensional covariates. Our approach is based on a two-step greedy tree algorithm to pursue signals in a high-dimensional space. In the first step, we transform the treatment selection problem into a weighted classification problem that can utilize tree-based methods. In the second step, we adopt a newly proposed tree-based method, known as reinforcement learning trees, to detect features involved in the optimal treatment rules and to construct binary splitting rules. The method is further extended to right censored survival data by using the accelerated failure time model and introducing double weighting to the classification trees. The performance of the proposed method is demonstrated via simulation studies, as well as analyses of the Cancer Cell Line Encyclopedia (CCLE) data and the Tamoxifen breast cancer data.

| S-EPMC5378692 | biostudies-literature

A machine learning approach to personalized dose adjustment of lamotrigine using noninvasive clinical parameters.

Project description:The pharmacokinetic variability of lamotrigine (LTG) plays a significant role in its dosing requirements. Our goal here was to use noninvasive clinical parameters to predict the dose-adjusted concentrations (C/D ratio) of LTG based on machine learning (ML) algorithms. A total of 1141 therapeutic drug-monitoring measurements were used, 80% of which were randomly selected as the "derivation cohort" to develop the prediction algorithm, and the remaining 20% constituted the "validation cohort" to test the finally selected model. Fifteen ML models were optimized and evaluated by tenfold cross-validation on the "derivation cohort," and were filtered by the mean absolute error (MAE). On the whole, the nonlinear models outperformed the linear models. The extra-trees' regression algorithm delivered good performance, and was chosen to establish the predictive model. The important features were then analyzed and parameters of the model adjusted to develop the best prediction model, which accurately described the C/D ratio of LTG, especially in the intermediate-to-high range (≥ 22.1 μg mL-1 g-1 day), as illustrated by a minimal bias (mean relative error (%) = + 3%), good precision (MAE = 8.7 μg mL-1 g-1 day), and a high percentage of predictions within ± 20% of the empirical values (60.47%). This is the first study, to the best of our knowledge, to use ML algorithms to predict the C/D ratio of LTG. The results here can help clinicians adjust doses of LTG administered to patients to minimize adverse reactions.

| S-EPMC7946912 | biostudies-literature

Augmented outcome-weighted learning for estimating optimal dynamic treatment regimens.

Project description:Dynamic treatment regimens (DTRs) are sequential treatment decisions tailored by patient's evolving features and intermediate outcomes at each treatment stage. Patient heterogeneity and the complexity and chronicity of many diseases call for learning optimal DTRs that can best tailor treatment according to each individual's time-varying characteristics (eg, intermediate response over time). In this paper, we propose a robust and efficient approach referred to as Augmented Outcome-weighted Learning (AOL) to identify optimal DTRs from sequential multiple assignment randomized trials. We improve previously proposed outcome-weighted learning to allow for negative weights. Furthermore, to reduce the variability of weights for numeric stability and improve estimation accuracy, in AOL, we propose a robust augmentation to the weights by making use of predicted pseudooutcomes from regression models for Q-functions. We show that AOL still yields Fisher-consistent DTRs even if the regression models are misspecified and that an appropriate choice of the augmentation guarantees smaller stochastic errors in value function estimation for AOL than the previous outcome-weighted learning. Finally, we establish the convergence rates for AOL. The comparative advantage of AOL over existing methods is demonstrated through extensive simulation studies and an application to a sequential multiple assignment randomized trial for major depressive disorder.

| S-EPMC6191367 | biostudies-literature

Multicategory Outcome Weighted Margin-based Learning for Estimating Individualized Treatment Rules.

Project description:Due to heterogeneity for many chronic diseases, precise personalized medicine, also known as precision medicine, has drawn increasing attentions in the scientific community. One main goal of precision medicine is to develop the most effective tailored therapy for each individual patient. To that end, one needs to incorporate individual characteristics to detect a proper individual treatment rule (ITR), by which suitable decisions on treatment assignments can be made to optimize patients' clinical outcome. For binary treatment settings, outcome weighted learning (OWL) and several of its variations have been proposed recently to estimate the ITR by optimizing the conditional expected outcome given patients' information. However, for multiple treatment scenarios, it remains unclear how to use OWL effectively. It can be shown that some direct extensions of OWL for multiple treatments, such as one-versus-one and one-versus-rest methods, can yield suboptimal performance. In this paper, we propose a new learning method, named Multicategory Outcome weighted Margin-based Learning (MOML), for estimating ITR with multiple treatments. Our proposed method is very general and covers OWL as a special case. We show Fisher consistency for the estimated ITR, and establish convergence rate properties. Variable selection using the sparse l 1 penalty is also considered. Analysis of simulated examples and a type 2 diabetes mellitus observational study are used to demonstrate competitive performance of the proposed method.

| S-EPMC7731977 | biostudies-literature

Dose-finding designs for cumulative toxicities using multiple constraints.

Project description:This article addresses the concern regarding late-onset dose-limiting toxicities (DLT), moderate toxicities below the threshold of a DLT and cumulative toxicities that may lead to a DLT, which are mostly disregarded or handled in an ad hoc manner when determining the maximum tolerated dose (MTD) in dose-finding cancer clinical trials. An extension of the Time-to-Event Continual Reassessment Method (TITE-CRM) which allows for the specification of toxicity constraints on both DLT and moderate toxicities, and can account for partial information is proposed. The method is illustrated in the context of an Erlotinib dose-finding trial with low DLT rates, but a significant number of moderate toxicities leading to treatment discontinuation in later cycles. Based on simulations, our method performs well at selecting the dose level that satisfies both the DLT and moderate-toxicity constraints. Moreover, it has similar probability of correct selection compared to the TITE-CRM when the true MTD based on DLT only and the true MTD based on grade 2 or higher toxicities alone coincide, but reduces the probability of recommending a dose above the MTD.

| S-EPMC6296314 | biostudies-literature

Optimal treatment regimes for competing risk data using doubly robust outcome weighted learning with bi-level variable selection.

Project description:The goal of the optimal treatment regime is maximizing treatment benefits via personalized treatment assignments based on the observed patient and treatment characteristics. Parametric regression-based outcome learning approaches require exploring complex interplay between the outcome and treatment assignments adjusting for the patient and treatment covariates, yet correctly specifying such relationships is challenging. Thus, a robust method against misspecified models is desirable in practice. Parsimonious models are also desired to pursue a concise interpretation and to avoid including spurious predictors of the outcome or treatment benefits. These issues have not been comprehensively addressed in the presence of competing risks. Recognizing that competing risks and group variables are frequently present, we propose a doubly robust estimation with adaptive L 1 penalties to select important variables at both group and within-group levels for competing risks data. The proposed method is applied to hematopoietic cell transplantation data to personalize the graft source choice for treatment-related mortality (TRM). While the existing medical literature attempts to find a uniform solution ignoring the heterogeneity of the graft source effects on TRM, the analysis results show the effect of the graft source on TRM could be different depending on the patient-specific characteristics.

| S-EPMC8117077 | biostudies-literature

VR4Health: Personalized teaching and learning anatomy using VR.

Project description:Virtual Reality (VR) is being integrated into many different areas of our lives, from industrial engineering to video-games, and also including teaching and education. We have several examples where VR has been used to engage students and facilitate their 3D spatial understanding, but can VR help also teachers? What are the benefits teachers can obtain on using VR applications? In this paper we present an application (VR4Health) designed to allow students to directly inspect 3D models of several human organs by using Virtual Reality systems. The application is designed to be used in an HMD device autonomously as a self-learning tool and also reports information to teachers in order that he/she becomes aware of what the students do and can redirect his/her work to the concrete necessities of the student. We evaluate both the students' and the teachers' perception by doing an experiment and asking them to fill-in a questionnaire at the end of the experiment.

| S-EPMC7082407 | biostudies-literature

Personalized machine learning of depressed mood using wearables.

Project description:Depression is a multifaceted illness with large interindividual variability in clinical response to treatment. In the era of digital medicine and precision therapeutics, new personalized treatment approaches are warranted for depression. Here, we use a combination of longitudinal ecological momentary assessments of depression, neurocognitive sampling synchronized with electroencephalography, and lifestyle data from wearables to generate individualized predictions of depressed mood over a 1-month time period. This study, thus, develops a systematic pipeline for N-of-1 personalized modeling of depression using multiple modalities of data. In the models, we integrate seven types of supervised machine learning (ML) approaches for each individual, including ensemble learning and regression-based methods. All models were verified using fourfold nested cross-validation. The best-fit as benchmarked by the lowest mean absolute percentage error, was obtained by a different type of ML model for each individual, demonstrating that there is no one-size-fits-all strategy. The voting regressor, which is a composite strategy across ML models, was best performing on-average across subjects. However, the individually selected best-fit models still showed significantly less error than the voting regressor performance across subjects. For each individual's best-fit personalized model, we further extracted top-feature predictors using Shapley statistics. Shapley values revealed distinct feature determinants of depression over time for each person ranging from co-morbid anxiety, to physical exercise, diet, momentary stress and breathing performance, sleep times, and neurocognition. In future, these personalized features can serve as targets for a personalized ML-guided, multimodal treatment strategy for depression.

| S-EPMC8187630 | biostudies-literature

Personalized Policy Learning using Longitudinal Mobile Health Data.

Project description:Personalized policy represents a paradigm shift from one-decision-rule-for-all users to an individualized decision rule for each user. Developing personalized policy in mobile health applications imposes challenges. First, for lack of adherence, data from each user are limited. Second, unmeasured contextual factors can potentially impact on decision making. Aiming to optimize immediate rewards, we propose using a generalized linear mixed modeling framework where population features and individual features are modeled as fixed and random effects, respectively, and synthesized to form the personalized policy. The group lasso type penalty is imposed to avoid overfitting of individual deviations from the population model. We examine the conditions under which the proposed method work in the presence of time-varying endogenous covariates, and provide conditional optimality and marginal consistency results of the expected immediate outcome under the estimated policies. We apply our method to develop personalized push ("prompt") schedules in 294 app users, with the goal to maximize the prompt response rate given past app usage and other contextual factors. The proposed method compares favorably to existing estimation methods including using the R function "glmer" in a simulation study.

| S-EPMC8259695 | biostudies-literature

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data